Basics Olema Pharmaceuticals, Inc. IPO Date: November 16, 2020 Sector: Healthcare Industry: Biotech Market Cap: $2.18B Activated in VL: True Average Daily Range Avg Daily Range: $0.51 | 3.94% Avg Daily Range (30 D): $0.66 | 3.87% Avg Daily Range (90 D): $0.42 | 3.94% Institutional Daily Volume Avg Daily Volume: .56M Avg Daily Volume (30 D): 4.65M Avg Daily Volume (90 D): 2.24M Trade Size Avg Trade Size (Sh.): 85 Avg Trade Size (Sh.) (30 D): 77 Avg Trade Size (Sh.) (90 D): 80 Institutional Trades Total Inst.Trades: 857 Avg Inst. Trade: $1.71M Avg Inst. Trade (30 D): $1.64M Avg Inst. Trade (90 D): $1.62M Avg Inst. Trade Volume: .14M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.09M Avg Closing Trade (30 D): $2.61M Avg Closing Trade (90 D): $1.99M Avg Closing Volume: 164.78K     News Nov 18, 2025 @ 9:51 PM Olema Oncology Announces Proposed Public Offering ... Source: Courtney O'Konek Nov 18, 2025 @ 5:01 PM Pharma Bro Martin Shkreli Shorts Olema Pharmaceuti... Source: Erica Kollmann Oct 18, 2025 @ 7:00 AM Olema Oncology Announces New Data from the Phase 1... Source: Olema Oncology May 28, 2025 @ 11:00 AM Olema Oncology Announces Palazestrant Dose Selecti... Source: N/A Apr 30, 2025 @ 5:00 PM Metastatic HR+/HER2- Breast Cancer Market—T... Source: Delveinsight Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.76 $-.49 $-.51 Diluted EPS $-1.76 $-.49 $-.51 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -149.96M $ -42.22M $ -43.78M Operating Income / Loss $ -165.38M $ -45.88M $ -47.86M Cost of Revenue $ $ $ Net Cash Flow $ -.63M $ -17.21M $ 1.83M PE Ratio